The FDA has once again approved belantamab mafodotin (Blenrep) for multiple myeloma, 3 years after the drug left the market over questions about its efficacy. A B-cell maturation antigen ...

(The Center Square) – Two Republican U.S. senators and a national pro-life organization say they want the Trump administration to explain why the U.S. Food and Drug Administration approved a new ...

President Donald Trump's approval rating is historically low, despite his claims to the contrary during a trip to Asia. A majority of Americans are frustrated or angry with the ongoing government ...

The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes. The drug, known generically as elinzanetant, is ...

GSK finally has the long-awaited FDA approval it sought for blood cancer drug Blenrep. Three years after the pharmaceutical giant pulled the multiple myeloma therapy from the market, the FDA approved ...

Treatment with belantamab mafodotin plus bortezomib and dexamethasone reduced the risk of death by 51% compared with the combination of daratumumab, bortezomib, and dexamethasone. The Food and Drug ...

The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help with sleep issues. By Nina Agrawal and Maggie Astor The Food and Drug ...

(WNDU) - Saturday is Prescription Drug Take Back Day, making it the perfect time to get rid of your unwanted medications to prevent prescription drug abuse. Indiana State Police, Michigan State Police ...

A new source casts doubt on reports that Ana de Armas and Tom Cruise ever dated, calling Tom a “dear friend” to Ana. Ana and Tom were rumored to have dated from February to October. The two actors are ...

After rejecting Replimune’s melanoma drug RP1 this summer, the FDA has accepted the biotech’s resubmission of an approval application. The federal agency said it expects to reach a decision on or ...

A new oral drug stands to become the first prescription pill specifically designed to regrow hair in both women and men. If approved following current Phase 3 trials, it would be the first new ...